Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Abroad (travel likely)RecruitingPHASE3

Conditions

Primary Central Nervous System Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospital Freiburg, Department Medicine I, Hematology, oncology and stem cell transplantation, Freiburg im Breisgau, Baden-Wurttemberg, Germany
Contact: Study coordinator (Elisabeth Schorb, MD) · elisabeth.schorb@uniklinik-freiburg.de · +4976127035360
Contact: Study coordinator (Lisa K Isbell, MD) · lisa.isbell@uniklinik-freiburg.de
Florian Scherer, MD (Sub-investigator)
Eliza Lauer, MD (Sub-investigator)
Klinikum Stuttgart, Clinic of Hematology, Oncology and Palliative Care, Stuttgart Cancer Center / Tumor Center Eva Mayr-Stihl, Stuttgart, Baden-Wurttemberg, Germany
Contact: Study coordinator (Gerald Illerhaus, PhD) · G.Illerhaus@klinikum-stuttgart.de · +49 711 278
Contact: Study coordinator (Julia Wendler, MD) · j.wendler@klinikum-stuttgart.de
University Hospital Aachen, Aachen, Germany
Contact: Study coordinator (Jens Panse, MD) · jpanse@ukaachen.de
University Hospital Augsburg, Augsburg, Germany
Contact: Study coordinator (Mathias Lutz, MD) · mathias.lutz@uk-augsburg.de
Helios Klinikum Berlin-Buch, Berlin, Germany
Contact: Study coordinator (Christian Eimermacher, MD) · Christian.eimermacher@helios-gesundheit.de
University Hospital Berlin, Berlin, Germany
Contact: Study coordinator (Ulrich Keller, MD) · ulrich.keller@charite.de
Evangelisches Klinikum Bethel, Bielefeld, Germany
Contact: Study coordinator (Bettina Zinngrebe, MD) · bettina.zinngrebe@evkb.de
Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany
Contact: Study coordinator (Sabine Seidel, MD) · Sabine.Seidel@kk-bochum.de
Städtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany
Contact: Study coordinator (Carsten Springer, MD) · c.springer@klinikum-braunschweig.de
Klinikum Bremen-Mitte gGmbH, Bremen, Germany
Contact: Study coordinator (Bernd Hertenstein, MD) · bernd.hertenstein@klinikum-bremen-mitte.de
Klinikum Chemnitz gGmbH, Chemnitz, Germany
Contact: Study coordinator (Mathias Hänel, MD) · m.haenel@skc.de
Universitätsklinikum Köln, Cologne, Germany
Contact: Study coordinator (Heger Jan-Michel, MD) · jan-michel.heger@uk-koeln.de
Carl Gustav Carus Universitätsklinikum Dresden, Dresden, Germany
Contact: Study coordinator (Frank Kroschinsky, MD) · frank.kroschinsky@uniklinikum-dresden.de
Universitätsklinikum Düsseldorf, Düsseldorf, Germany
Contact: Study coordinator (Guido Kobbe, MD) · kobbe@med.uni-duesseldorf.de
Universitätsklinikum Erlangen, Erlangen, Germany
Contact: Study coordinator (Stefan Krause, MD) · stefan.krause@uk-erlangen.de
Universitätsklinikum Essen, Essen, Germany
Contact: Study coordinator (Bastian von Tresckow, MD) · bastian.vontresckow@uk-essen.de
Klinikum der Johann-Wolfgang-Goethe-Universität, Frankfurt, Germany
Contact: Study coordinator (Thomas Oellerich, MD) · thomas.oellerich@kgu.de
Universitätsmedizin Göttingen Georg-August-Universität, Göttingen, Germany
Contact: Study coordinator (Justin Hasenkamp, MD) · j.hasenkamp@med.uni-goettingen.de
Universitätsklinikum Halle (Saale), Halle, Germany
Contact: Study coordinator (Thomas Weber, MD) · thomas.weber@uk-halle.de
Universitätsklinikum des Saarlandes Homburg, Homburg, Germany
Contact: Study coordinator (Lorenz Thurner, MD) · lorenz.thurner@uks.eu
Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
Contact: Study coordinator (Martin Bentz, MD) · martin.bentz@klinikum-karlsruhe.de
Universitätsklinkum Schleswig-Holstein, Campus Kiel, Kiel, Germany
Contact: Study coordinator (Christine Pott, MD) · c.pott@med2.uni-kiel.de
Gemeinschaftsklinikum Mittelrhein gGmbH - Koblenz Ev. Stift St. Martin, Koblenz, Germany
Contact: Study coordinator (Niemann Dirk, MD) · Dirk.Niemann@gk.de
Universitätsklinikum Leipzig, Leipzig, Germany
Contact: Study coordinator (Simone Heyn, MD) · Simone.Heyn@medizin.uni-leipzig.de
Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
Contact: Study coordinator (Nicolas von Bubnoff, MD) · nikolas.vonBubnoff@uksh.de
Klinikum rechts der Isar TU München, München, Germany
Contact: Study coordinator (Lena Illert, MD) · lena.illert@tum.de
Universitätsklinikum Münster, Münster, Germany
Contact: Study coordinator (Andrea Kerkhoff, MD) · andrea.kerkhoff@ukmuenster.de
Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Nuremberg, Germany
Contact: Study coordinator (Alexander Bott, MD) · alexander.bott@klinikum-nuernberg.de
Pius-Hospital Oldenburg, Oldenburg, Germany
Contact: Study coordinator (Johannes Hoffmann, MD) · johannes.hoffmann@pius-hospital.de
Klinikum Oldenburg gGmbh, Oldenburg in Holstein, Germany
Contact: Study coordinator (Christoph Kimmich, MD) · kimmich.christoph@klinikum-oldenburg.de
Universitätsklinikum Regensburg, Regensburg, Germany
Contact: Study coordinator (Florian Lüle, MD) · Florian.Lueke@klinik.uni-regensburg.de
Universitätsmedizin Rostock, Rostock, Germany
Contact: Study coordinator (Christoph Wittke, MD) · christoph.wittke@med.uni-rostock.de
Universtitätsklinikum Tübingen, Tübingen, Germany
Contact: Study coordinator (Robert Möhle, MD) · robert.moehle@med.uni-tuebingen.de
Universitätsklinikum Ulm, Ulm, Germany
Contact: Study coordinator (Andreas Viardot, MD) · andreas.viardot@uniklinik-ulm.de
Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Villingen-Schwenningen, Germany
Contact: Study coordinator (Paul La Rosée, MD) · paul.laRosee@sbk-vs.de

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Tampa, United States

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Relapsed/Refractory Primary Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Scottsdale, United States

Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma

CNS Lymphoma · Primary Central Nervous System Lymphoma · Secondary Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Francisco, United States

DALY II USA/ MB-CART2019.1 for DLBCL

Refractory Diffuse Large B Cell Lymphoma (DLBCL) · Relapsed Diffuse Large B Cell Lymphoma · High Grade B-cell Lymphoma (HGBCL)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Gilbert, United States